Related Experiment Video
Updated: Sep 3, 2025
Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
Neurogenetic and Metabolic Mimics of Common Neonatal Neurological Disorders
William Burns1, Bimal P Chaudhari2, Darrah N Haffner3
1Division of Genetics and Genomic Medicine, Nationwide Children's Hospital, Columbus, OH; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH.
Insights
Prompt identification of neonatal neurogenetic and metabolic diseases is crucial. Early diagnosis and condition-specific treatments can significantly improve neurodevelopment and seizure outcomes in infants.
Area of Science:
- Pediatric Neurology
- Metabolic Disorders
- Neurogenetics
Background:
- Neonatal neurogenetic and metabolic diseases often mimic other conditions, primarily neonatal encephalopathy and seizures.
- These disorders require a high index of suspicion for timely diagnosis and intervention.
Purpose of the Study:
- To highlight the importance of early detection and treatment of neonatal neurogenetic and metabolic diseases.
- To emphasize the role of advanced diagnostics and targeted therapies in improving patient outcomes.
Main Methods:
- Review of current understanding of inborn errors of metabolism.
- Discussion of diagnostic approaches including simultaneous metabolic and molecular testing.
- Emphasis on concurrent treatment strategies.
Main Results:
- Advancements in understanding inborn errors of metabolism have led to new therapeutic options.
- Many treatments can enhance long-term neurodevelopment and seizure control.
- Treatment efficacy is often condition-specific, necessitating precise diagnosis.
Conclusions:
- Prompt identification and treatment of neonatal neurogenetic and metabolic diseases are critical.
- Simultaneous metabolic and molecular testing, alongside concurrent treatment, is recommended upon suspicion.
- Early intervention significantly impacts neurodevelopmental trajectories and seizure management in affected neonates.
Abstract:
Neurogenetic and metabolic diseases often present in the neonatal period, masquerading as other disorders, most commonly as neonatal encephalopathy and seizures. Advancements in our understanding of inborn errors of metabolism are leading to an increasing number of therapeutic options. Many of these treatments can improve long-term neurodevelopment and seizure control. However, the treatments are frequently condition-specific. A high index of suspicion is required for prompt identification and treatment. When suspected, simultaneous metabolic and molecular testing are recommended along with concurrent treatment.
